U.S. markets closed
  • S&P Futures

    4,205.50
    -17.50 (-0.41%)
     
  • Dow Futures

    33,914.00
    -103.00 (-0.30%)
     
  • Nasdaq Futures

    13,894.25
    -87.00 (-0.62%)
     
  • Russell 2000 Futures

    2,298.30
    -11.80 (-0.51%)
     
  • Crude Oil

    71.59
    -0.56 (-0.78%)
     
  • Gold

    1,818.70
    -42.70 (-2.29%)
     
  • Silver

    27.22
    -0.60 (-2.15%)
     
  • EUR/USD

    1.1989
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3973
    -0.0014 (-0.10%)
     
  • USD/JPY

    110.8070
    +0.1940 (+0.18%)
     
  • BTC-USD

    38,551.44
    -1,575.54 (-3.93%)
     
  • CMC Crypto 200

    956.90
    -35.57 (-3.58%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    29,291.01
    0.00 (0.00%)
     

Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug

·3 min read
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
  • Oops!
    Something went wrong.
    Please try again later.

The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir.